Table 2.
BMI | WC | TAV | VAV | SAVa | VAV%b | |
---|---|---|---|---|---|---|
Sex steroids | ||||||
Estradiol (pmol/L) | .62** | .64** | .74** | .58** | .74** | −.06 |
Androstenedione (nmol/L) | .26 | .33* | .37* | .29 | .43** | −.17 |
Testosterone (nmol/L) | .17 | .31 | .29 | .19 | .31 | −.15 |
DHEAS (μmol/L) | .36* | .31 | .30 | .35* | .34* | −.10 |
Lipids | ||||||
Cholesterol (mmol/L) | −.07 | −.08 | −.19 | −.08 | −.20 | .01 |
HDL (mmol/L) | −.23 | −.37* | −.45** | −.39* | −.42** | −.15 |
LDL (mmol/L) | −.03 | −.03 | −.13 | −.02 | −.12 | −.01 |
NHDL (mmol/L) | −.00 | .01 | −.08 | .01 | −.09 | .05 |
Triglycerides (mmol/L) | −.05 | .17 | .15 | .14 | .09 | .36* |
Chol/HDL ratio | .17 | .27 | .29 | .30 | .27 | --.13 |
a SAV analysis is limited to 38 patients, b proportion of VAV in relation to TAV, * p < 0.05, **p < 0.01